BDBM593217 N-((1R,4R)-4-(((5-fluoro-2-((1- isopropyl-3-methyl-1H-pyrazol-4- yl)amino)pyrimidin-4- yl)oxy)methyl)cyclohexyl) acetamide::US11578061, Example 195
SMILES CC(=O)N[C@H]1CC[C@H](COc2nc(Nc3cn(C(C)C)nc3C)ncc2F)CC1
InChI Key InChIKey=UNSYCAXSZSQWLO-UHFFFAOYSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 593217
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [970-2527](Human)
Halia Therapeutics
US Patent
Halia Therapeutics
US Patent
Affinity DataIC50: 50nMAssay Description:LRRKtide substrate (peptide sequence RLGRDKYKTLRQIRQ, derived from human ezrin [amino acids 561-573], moesin [amino acids 539-553] and radixin [amino...More data for this Ligand-Target Pair
